In vitro and ex vivo blocking experiments in several types of cancer illustrated the role of CD44 as adhesion molecule in PM formation [44, 64–70] and particularly indicated a role for the CD44 s splice variant [28, 30, 70]. The gene discussed is CD44; the disease is cancer.